Matthew J. Marton

25.1k total citations · 4 hit papers
45 papers, 10.6k citations indexed

About

Matthew J. Marton is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Matthew J. Marton has authored 45 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 21 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Matthew J. Marton's work include Cancer Genomics and Diagnostics (11 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Molecular Biology Techniques and Applications (7 papers). Matthew J. Marton is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Molecular Biology Techniques and Applications (7 papers). Matthew J. Marton collaborates with scholars based in United States, Denmark and United Kingdom. Matthew J. Marton's co-authors include Hongyue Dai, Stephen Friend, Yudong D. He, Augustinus A. M. Hart, Mao Mao, Chris Roberts, Marc J. van de Vijver, George J. Schreiber, Anke Witteveen and Peter S. Linsley and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Matthew J. Marton

42 papers receiving 10.3k citations

Hit Papers

Gene expression profiling... 1998 2026 2007 2016 2002 2000 2001 1998 2.0k 4.0k 6.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew J. Marton United States 18 7.5k 2.8k 2.5k 1.4k 767 45 10.6k
Yudong D. He United States 27 6.8k 0.9× 3.2k 1.1× 2.8k 1.1× 1.3k 0.9× 828 1.1× 49 10.6k
Mao Mao United States 37 8.6k 1.1× 3.6k 1.3× 2.8k 1.2× 1.5k 1.1× 1.1k 1.4× 108 13.5k
Eivind Hovig Norway 46 6.0k 0.8× 2.3k 0.8× 2.2k 0.9× 1.1k 0.8× 781 1.0× 218 8.9k
Manfred Schwab Germany 48 8.1k 1.1× 2.9k 1.0× 2.5k 1.0× 2.2k 1.7× 667 0.9× 150 12.4k
Hongyue Dai United States 34 9.3k 1.2× 4.4k 1.6× 3.4k 1.4× 1.5k 1.1× 1.1k 1.4× 66 14.2k
Jeffrey T. Chang United States 38 6.6k 0.9× 1.6k 0.6× 1.5k 0.6× 888 0.7× 657 0.9× 109 9.5k
Benjamin J. Raphael United States 40 6.5k 0.9× 3.5k 1.2× 1.5k 0.6× 1.8k 1.3× 839 1.1× 127 8.9k
Joshua M. Stuart United States 40 9.8k 1.3× 3.5k 1.3× 1.7k 0.7× 1.3k 1.0× 1.8k 2.3× 108 13.6k
Shridar Ganesan United States 52 7.8k 1.0× 3.1k 1.1× 3.5k 1.4× 1.6k 1.2× 1.4k 1.8× 204 12.7k
Ron Kerkhoven Netherlands 40 10.8k 1.4× 3.5k 1.3× 4.7k 1.9× 1.9k 1.4× 955 1.2× 77 15.4k

Countries citing papers authored by Matthew J. Marton

Since Specialization
Citations

This map shows the geographic impact of Matthew J. Marton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. Marton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. Marton more than expected).

Fields of papers citing papers by Matthew J. Marton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew J. Marton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. Marton. The network helps show where Matthew J. Marton may publish in the future.

Co-authorship network of co-authors of Matthew J. Marton

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew J. Marton. A scholar is included among the top collaborators of Matthew J. Marton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew J. Marton. Matthew J. Marton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cristescu, Răzvan, Xiao Qiao Liu, Gladys Arreaza, et al.. (2022). Concordance between single-nucleotide polymorphism–based genomic instability assays and a next-generation sequencing–based homologous recombination deficiency test. BMC Cancer. 22(1). 1310–1310. 5 indexed citations
2.
Steiniche, Torben, Morten Ladekarl, Simon Andreasen, et al.. (2020). Association of PD-L1 Expression with Prognosis Among Patients with Ten Uncommon Advanced Cancers. Future Science OA. 6(8). FSO616–FSO616. 9 indexed citations
3.
Høgdall, Estrid, Claus Høgdall, Wei Zhou, et al.. (2020). Impact of PD-L1 and T-cell inflamed gene expression profile on survival in advanced ovarian cancer. International Journal of Gynecological Cancer. 30(7). 1034–1042. 8 indexed citations
4.
Antonarakis, Emmanuel S., Marine Gross‐Goupil, Jeffrey C. Goh, et al.. (2020). Biomarker analysis from the KEYNOTE-199 trial of pembrolizumab in patients (pts) with docetaxel-refractory metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 38(15_suppl). 5526–5526. 11 indexed citations
5.
Steiniche, Torben, Sun Young Rha, Hyun Cheol Chung, et al.. (2019). T-cell–inflamed gene expression profile (GEP) and PD-L1 expression in patients (pts) with esophageal cancer (EC).. Journal of Clinical Oncology. 37(4_suppl). 26–26.
6.
Wallden, Brett, Irena Pekker, Naeem Dowidar, et al.. (2016). Development and analytical performance of a molecular diagnostic for anti-PD1 response on the nCounter Dx Analysis System.. Journal of Clinical Oncology. 34(15_suppl). 3034–3034. 16 indexed citations
7.
Marton, Matthew J., et al.. (2015). Analytical Validation of AmpliChip p53 Research Test for Archival Human Ovarian FFPE Sections. PLoS ONE. 10(6). e0131497–e0131497. 3 indexed citations
8.
Lejnine, Serguei, Matthew J. Marton, Bonnie J. Howell, et al.. (2014). Gene expression analysis in serial liver fine needle aspirates. Journal of Viral Hepatitis. 22(1). 64–76. 7 indexed citations
9.
Chang, Ken C. N., Stefan Galuska, Russell Weiner, & Matthew J. Marton. (2013). Development and Validation of a Clinical Trial Patient Stratification Assay That Interrogates 27 Mutation Sites in MAPK Pathway Genes. PLoS ONE. 8(8). e72239–e72239. 1 indexed citations
10.
Winrow, Christopher J., Keith Q. Tanis, Alison Rigby, et al.. (2009). Refined anatomical isolation of functional sleep circuits exhibits distinctive regional and circadian gene transcriptional profiles. Brain Research. 1271. 1–17. 13 indexed citations
11.
Duenwald, Sven, Mingjie Zhou, Yanqun Wang, et al.. (2009). Development of a microarray platform for FFPET profiling: application to the classification of human tumors. Journal of Translational Medicine. 7(1). 65–65. 14 indexed citations
12.
Fare, Thomas L., Ernest M. Coffey, Hongyue Dai, et al.. (2003). Effects of Atmospheric Ozone on Microarray Data Quality. Analytical Chemistry. 75(17). 4672–4675. 166 indexed citations
13.
Anand, Monika, Kalpana Chakraburtty, Matthew J. Marton, Alan G. Hinnebusch, & Terri Goss Kinzy. (2003). Functional Interactions between Yeast Translation Eukaryotic Elongation Factor (eEF) 1A and eEF3. Journal of Biological Chemistry. 278(9). 6985–6991. 57 indexed citations
15.
Nelson, Bryce, et al.. (2001). Role of scaffolds in MAP kinase pathway specificity revealed by custom design of pathway-dedicated signaling proteins. Current Biology. 11(23). 1815–1824. 94 indexed citations
16.
Hughes, Timothy R., Chris Roberts, Hongyue Dai, et al.. (2000). Widespread aneuploidy revealed by DNA microarray expression profiling. Nature Genetics. 25(3). 333–337. 384 indexed citations
17.
Roberts, Christopher J., Bryce Nelson, Matthew J. Marton, et al.. (2000). Signaling and Circuitry of Multiple MAPK Pathways Revealed by a Matrix of Global Gene Expression Profiles. Science. 287(5454). 873–880. 691 indexed citations breakdown →
18.
Marton, Matthew J., Joseph L. DeRisi, Vishwanath R. Iyer, et al.. (1998). Drug target validation and identification of secondary drug target effects using DNA microarrays. Nature Medicine. 4(11). 1293–1301. 479 indexed citations breakdown →
19.
Marton, Matthew J., Carlos R. Vázquez de Aldana, Hongfang Qiu, Kalpana Chakraburtty, & Alan G. Hinnebusch. (1997). Evidence that GCN1 and GCN20, Translational Regulators of GCN4 , Function on Elongating Ribosomes in Activation of eIF2α Kinase GCN2. Molecular and Cellular Biology. 17(8). 4474–4489. 184 indexed citations
20.
Marton, Matthew J., et al.. (1964). COUNTERACTION TO AND PREVENTION OF, DIFFERENT ANXIETY TYPES IN ASTHMATIC, CARDIAC NEUROTIC AND HYPERTENSIVE CHILDREN.. PubMed. 31. 157–61. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026